Partial orphan cancer drugs: US food and drug administration approval, clinical benefit, trials, epidemiology, price, beneficiaries, and spending
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
18 January 2024
|
| In: |
Value in health
Year: 2024, Volume: 27, Issue: 4, Pages: 449-457 |
| ISSN: | 1524-4733 |
| DOI: | 10.1016/j.jval.2024.01.002 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jval.2024.01.002 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1098301524000305 
|
| Author Notes: | Thomas Michaeli, Daniel Tobias Michaeli |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1907031200 | ||
| 003 | DE-627 | ||
| 005 | 20241205183340.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 241028s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jval.2024.01.002 |2 doi | |
| 035 | |a (DE-627)1907031200 | ||
| 035 | |a (DE-599)KXP1907031200 | ||
| 035 | |a (OCoLC)1475317169 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Michaeli, Christoph T. |d 1992- |e VerfasserIn |0 (DE-588)1277182337 |0 (DE-627)1830343769 |4 aut | |
| 245 | 1 | 0 | |a Partial orphan cancer drugs |b US food and drug administration approval, clinical benefit, trials, epidemiology, price, beneficiaries, and spending |c Thomas Michaeli, Daniel Tobias Michaeli |
| 264 | 1 | |c 18 January 2024 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 28.10.2024 | ||
| 650 | 4 | |a cancer drug | |
| 650 | 4 | |a clinical trial | |
| 650 | 4 | |a drug development | |
| 650 | 4 | |a drug spending | |
| 650 | 4 | |a epidemiology | |
| 650 | 4 | |a Medicaid | |
| 650 | 4 | |a Medicare | |
| 650 | 4 | |a orphan designation | |
| 650 | 4 | |a overall survival | |
| 650 | 4 | |a partial orphan | |
| 650 | 4 | |a price | |
| 650 | 4 | |a progression-free survival | |
| 650 | 4 | |a rare diseases | |
| 700 | 1 | |a Michaeli, Daniel |d 1997- |e VerfasserIn |0 (DE-588)1277183244 |0 (DE-627)1830345109 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Value in health |d Amsterdam [u.a.] : Elsevier, 1998 |g 27(2024), 4, Seite 449-457 |h Online-Ressource |w (DE-627)32049117X |w (DE-600)2011039-X |w (DE-576)09116978X |x 1524-4733 |7 nnas |a Partial orphan cancer drugs US food and drug administration approval, clinical benefit, trials, epidemiology, price, beneficiaries, and spending |
| 773 | 1 | 8 | |g volume:27 |g year:2024 |g number:4 |g pages:449-457 |g extent:9 |a Partial orphan cancer drugs US food and drug administration approval, clinical benefit, trials, epidemiology, price, beneficiaries, and spending |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jval.2024.01.002 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1098301524000305 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20241028 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 1277183244 |a Michaeli, Daniel |m 1277183244:Michaeli, Daniel |d 910000 |d 910100 |e 910000PM1277183244 |e 910100PM1277183244 |k 0/910000/ |k 1/910000/910100/ |p 2 |y j | ||
| 998 | |g 1277182337 |a Michaeli, Christoph T. |m 1277182337:Michaeli, Christoph T. |d 60000 |d 61400 |e 60000PM1277182337 |e 61400PM1277182337 |k 0/60000/ |k 1/60000/61400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1907031200 |e 4603611021 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 28.10.2024"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"18 January 2024","dateIssuedKey":"2024"}],"title":[{"title_sort":"Partial orphan cancer drugs","subtitle":"US food and drug administration approval, clinical benefit, trials, epidemiology, price, beneficiaries, and spending","title":"Partial orphan cancer drugs"}],"person":[{"given":"Christoph T.","family":"Michaeli","display":"Michaeli, Christoph T.","role":"aut"},{"role":"aut","display":"Michaeli, Daniel","given":"Daniel","family":"Michaeli"}],"language":["eng"],"physDesc":[{"extent":"9 S."}],"relHost":[{"note":["Gesehen am 01.12.2023","Fortsetzung der Druck-Ausgabe"],"pubHistory":["1.1998 -"],"title":[{"title":"Value in health","subtitle":"the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)","title_sort":"Value in health"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"1998","dateIssuedDisp":"1998-","publisherPlace":"Amsterdam [u.a.] ; Malden, Mass. ; Oxford [u.a.] ; Oxford [u.a.]","publisher":"Elsevier ; Blackwell Science ; Blackwell ; Wiley-Blackwell"}],"part":{"extent":"9","volume":"27","pages":"449-457","text":"27(2024), 4, Seite 449-457","year":"2024","issue":"4"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Partial orphan cancer drugs US food and drug administration approval, clinical benefit, trials, epidemiology, price, beneficiaries, and spendingValue in health","language":["eng"],"id":{"doi":["10.1111/(ISSN)1524-4733"],"issn":["1524-4733"],"zdb":["2011039-X"],"eki":["32049117X"]},"recId":"32049117X"}],"name":{"displayForm":["Thomas Michaeli, Daniel Tobias Michaeli"]},"id":{"doi":["10.1016/j.jval.2024.01.002"],"eki":["1907031200"]},"recId":"1907031200"} | ||
| SRT | |a MICHAELICHPARTIALORP1820 | ||